Original Antigenic Sin – the Hidden Danger of COVID Shots
Joseph Mercola Scientists warn repeated COVID boosters may result in lowered immunity through a process known as “original antigenic sin” or “immune imprinting”. Original antigenic sin describes how your first exposure to a virus shapes the outcome of subsequent exposures to antigenically related strains. The end result is that you become increasingly prone to symptomatic […]
Pfizer/BioNTech COVID-19 Omicron-Modified Vaccine Options
Pfizer/BioNTech June 28, 2022 Presentation to the Vaccines and Related Biological Products Advisory Committee
1.4 Million Adverse Events after COVID Vaccines Reported to VAERS, Canadian Woman Dies 7 Minutes after Bivalent Booster Shot
Megan Redshaw The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,418, 220 reports of adverse events following COVID-19 vaccines were submitted between Dec. 14, 2020, and Sept. 16, 2022, to the Vaccine Adverse Event Reporting System (VAERS). That’s an increase of 10,811 adverse events over the previous […]
The High-Speed, Bivalent COVID Boosters are Here
Meryl Nass On Wednesday, August 31, the FDA issued emergency use authorizations for new Pfizer and Moderna mRNA booster vaccines for COVID. The next day, September 1, the CDC’s advisory committee and CDC Director approved the immediate rollout of the new vaccines. They will be administered in the US starting this week. Surprisingly, more than […]
Rapid Rollout of New COVID Boosters with nNo Human Trials – ‘A Tale of Recklessness’
Meryl Nass The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) cooperated to issue Emergency Use Authorizations (EUA) and roll out new, bivalent Pfizer and Moderna COVID-19 vaccines this week, without any human trials, which is unprecedented. There is international coordination regarding bivalent boosters, and a major effort […]
If It’s Okay for Mice, It’s Good Enough for People. Right?
Madhava Setty The U.S. Food and Drug Administration appears set to circumvent its own regulatory process in order to authorize Pfizer’s new bivalent COVID-19 vaccine that targets the Omicron BA.4 and BA.5 subvariants — without requiring clinical trials on humans. … Yes, it’s an unprecedented move by the FDA, but Dr. Ofer Levy, professor of […]
